Neurocrine Biosciences Inc - Company Profile
Powered by 
All the data and insights you need on Neurocrine Biosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Neurocrine Biosciences Inc Strategy Report
- Understand Neurocrine Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Neurocrine Biosciences Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Neurocrine Biosciences Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
William H. Rastetter, Ph.D.
Chairman Executive BoardMr. William H. Rastetter has been the Chairman of the company since 2011. Prior to this, he served as the Executive Chairman of Biogen Idec Inc. Mr. Rastetter also served as the Chief Executive Officer of IDEC Pharmaceuticals Corporation. Currently, he also serves as the Chairman of the Board of Directors for Fate Therapeutics.
Kevin C. Gorman, Ph.D.
Chief Executive Officer; Director Executive BoardMr. Kevin C. Gorman has been the Chief Executive Officer and Director of the company since 2008. Prior to this, he served the President of the company between 2008 and 2016. Mr. Gorman also served as the Chief Operating Officer, Executive Vice President and Chief Business Officer and Senior Vice President of business development of Neurocrine Biosciences.
Matthew C. Abernethy
Chief Financial Officer Senior ManagementMr. Matthew C. Abernethy has been the Chief Financial Officer of the company since 2017. Prior to this, he served as the Vice President, Investor Relations and Treasurer and Vice President of Finance for the Americas and Global Product Engines at Zimmer Biomet. Mr. Abernethy also served as the Certified Public Accountant at KPMG LLP.
Kyle W. Gano, Ph.D
Chief Strategy Officer; Chief Business Development Officer Senior ManagementDr. Kyle W. Gano has been the Chief Business Development Officer and Chief Strategy Officer of the company since 2020. Prior to this, he served as the Chief Business Development Officer of the company. Dr. Gano held several positions of increasing responsibility at Neurocrine Biosciences spanning marketing analytics to business development.
Darin M. Lippoldt
Chief Legal Officer; Secretary Senior ManagementMr. Darin M. Lippoldt has been the Chief Legal Officer and Secretary of the company since 2014. Prior to this, he served as the Executive Vice President and General Counsel of Volcano Corporation. Mr. Lippoldt also served as the Associate General Counsel at Amylin Pharmaceuticals, Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer